In 2015, Rivaroxaban powder accounted for the highest number of reported cases of serious injury among regularly monitored drugs to the FDA’s Adverse Events Reporting System (AERS).
Am 2015 huet Rivaroxaban Pudder fir déi héchste Unzuel vu berichtleche Fällen vun enger schlechter Verletzung ënner regelméisseg iwwerworfene Drogen op de FDA's Adverse Events Reporting System (AERS).